INS and obesity due to melanocortin 4 receptor deficiency: Accordingly, we have recently demonstrated that sustained (P3)PP administration exerts positive effects on islet cell turnover, leading to augmented beta-cell mass and pancreatic insulin content in a rodent model of obesity-diabetes [4].